UL
The United Laboratories International Holdings Limited
ULIHF · OTC
$1.02 +0.52% (+$0.01)
1M -8.11%
Market Cap ¥13.4B
P/E Ratio 6.59x
Div. Yield 3.76%
ROE 12.59%
Bulios Fair Price
$1.47
44.8% upside
Current Price
$1.02
Undervalued Fair Value Overvalued
According to Bulios Fair Price, ULIHF is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Piotroski F-Score Moderate
4/9Valuation
96 /100
Cheap P/E 6.59x
P/B 0.77x
EV/EBITDA 2.51x
Growth
39 /100
Stable EPS growth 6.47%
Book val. growth 17.94%
Rev. growth 4.33%
Profitability
71 /100
Strong Gross margin 41.74%
FCF margin 6.65%
Net margin 15.79%
Quality
50 /100
Average ROIC 7.96%
Asset turnover 0.42x
ROE 12.59%
Debt
99 /100
Low Debt/Equity 0.29x
Net debt/EBITDA -2.20x
Current ratio 1.83x
Stability
54 /100
Moderate Beta 0.29x
Profitable years 6
Rev. volatility 14.46%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about ULIHF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Hoi Shan Tsoi
Employees
18,000
Headquarters
Yuen Long
Upcoming events
30 MAR
Earnings
Upcoming earnings report